Tag Archives: health

FDA Safety and Innovation Act: A Step Forward for Patients With Rare Diseases

Peter L. Saltonstall

By Peter L. Saltonstall, President and CEO, National Organization for Rare Disorders (NORD) The Food and Drug Administration Safety and Innovation Act (FDASIA) includes the most groundbreaking measures for rare disease patients and their families since the Orphan Drug Act of 1983.  And, just as the rare disease patient community—with NORD as its unifying voice—played a major role in the Orphan Drug Act, NORD and rare disease patients have taken a leadership role in developing Read More >

Health  |  13 Comments  |  Email This Post
Tags: , , , , , , , , ,

Vaccines Beyond 2012

polio-vaccine

Each year, approximately 1.7 million children die from a vaccine-preventable disease, and the vast majority of these deaths occur in developing countries. This BIO 2012 session, moderated by Peg Willingham of the United Nations Foundation, addressed various ways industry can help increase access to life-saving vaccines for children and adults in resource-poor countries. The thoughts of a few of the speakers on the panel for this session are summarized below. The panelists suggested that for Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Cause Endures

t-kennedy-cause

By David Welch, M2 MultiMedia Communications In producing this short form mini-documentary, I learned that neither the conservatives who tried always to make Senator Ted Kennedy the poster child of all that was liberal nor the die-hard liberals who adored his every move had him quite right. This is especially true when examining his aggressive pursuit of his lifelong cause to improve the health of patients. It was a cause that propelled him into an Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Analysis and Impact of PDUFA V

hamburg

As the House of Representatives voted unanimously to approve legislation to approve the Prescription Drug User Fee Act (PDUFA) V, industry leaders gathered at the 2012 BIO International Convention for a lively discussion on the changes the new legislation, focused on modernizing Food and Drug Administration regulations, will bring to the biotechnology industry. The super session panel discussion was moderated by Steve Usdin, Washington Editor of BioCentury and Co-Host of BioCentury This Week, and included Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

From Bench to Bedside in a Bioeconomy

lab_tech02-btn

By Joe Allen, President, Allen and Associates It’s a sign of a well crafted program when the closing panel reinforces the opening speaker. Boston University President Robert Brown kicked off the afternoon at the Translational Research Forum at the 2012 BIO International Convention by showing how the old linear model of product development crafted after World War II no longer applies. The closing industry panel aptly remarked that a struggling economy has brought the public and private Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,